Organon & Co. OGN
i
Market dataready · fetched 2026-11-12T02:02:25.772Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:00:00.002725322Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-12T02:02:25.376044+00:00
Organon & Co. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | 21.03 | 336.9% | 59.1% | |||
| 35Δ | 17.88 | 268.6% | 36.7% | |||
| 40Δ | 17.11 | 259.9% | 32.7% | |||
| 45Δ | 16.35 | 251.2% | 28.7% | |||
| 50Δ | 15.58 | 242.4% | 24.8% | 14.27 | 134.9% | 7.2% |
| 55Δ | 14.81 | 233.7% | 20.8% | 14.81 | 155.0% | 7.0% |
| 60Δ | 14.05 | 225.0% | 16.8% | |||
| 65Δ | 13.28 | 216.3% | 12.8% | 16.16 | 191.6% | 6.5% |
| 70Δ | 12.51 | 207.6% | 8.8% | |||
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 21.03
- IV
- 336.9%
- B/E move
- 59.1%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 17.88
- IV
- 268.6%
- B/E move
- 36.7%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 17.11
- IV
- 259.9%
- B/E move
- 32.7%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 16.35
- IV
- 251.2%
- B/E move
- 28.7%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 15.58
- IV
- 242.4%
- B/E move
- 24.8%
- Pseudo strike
- 14.27
- IV
- 134.9%
- B/E move
- 7.2%
55Δ
- Pseudo strike
- 14.81
- IV
- 233.7%
- B/E move
- 20.8%
- Pseudo strike
- 14.81
- IV
- 155.0%
- B/E move
- 7.0%
60Δ
- Pseudo strike
- 14.05
- IV
- 225.0%
- B/E move
- 16.8%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 13.28
- IV
- 216.3%
- B/E move
- 12.8%
- Pseudo strike
- 16.16
- IV
- 191.6%
- B/E move
- 6.5%
70Δ
- Pseudo strike
- 12.51
- IV
- 207.6%
- B/E move
- 8.8%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 85.47% | |
| 96.00% | |
| 84.96% | |
| 109.24% | |
| 112.91% | |
| 113.53% | |
| 76.38% | |
| 103.86% | |
| 71.46% |
Drug Manufacturers - General
PFE
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company…
More →SNY
Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The…
More →ABBV
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
More →AMGN
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular…
More →AMRN
Description unavailable
More →AZN
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections,…
More →